semaglutide causing blindness and eye vision A new study suggests patients taking — the active ingredient in Ozempic Wegovy — may be at higher risk of developing an condition that can cause blindness. Non-arteritic Understanding Semaglutide and Its Impact

In WEGOVY clinical trials in adults for weight reduction, severe gastrointestinal adverse reactions were reported more frequently among patients receiving WEGOVY (4.1%) than placebo (0.9%)

However, results start to regress when the injections are stopped

"*" indicates required fields The Benefits of Ozempic Injections Ozempic injections are tailored for adults who are considered obese, with a body mass index (BMI) of 30 or higher, or those who are overweight (BMI of 27 or higher) with at least one weight-related health condition such as hypertension

Why Do I Need to Stop Semaglutide Before Surgery

Many people experience a significant reduction in body weight when combined with a healthy diet and regular exercise